ConductScience.org, home

Paper412648

Antimicrobial synergism in the therapy of gram-negative rod bacteremia.

Anderson ET and 2 others. Chemotherapy, 1978. Cited by 180 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Papers, record 412648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412648

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
PubMed
Journal
Chemotherapy
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
180
iCite
Relative citation ratio, by iCite
7.8
iCite
Revised in PubMed
2018-02-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anderson ETE T
2Young LSL S
3Hewitt WLW L

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
SepsisMajor topic
Aminoglycosides
Ampicillin
Carbenicillin
Cephalosporins
Drug Evaluation
Drug Synergism
Drug Therapy, Combination
Escherichia coli
Humans
Klebsiella pneumoniae
Microbial Sensitivity Tests
Proteus
Pseudomonas aeruginosa
Serratia marcescens

Source PubMed

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.

PMIDTitleJournalYearIn PapersSource
41,148,672Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis.Antibiotics (Basel)2025https://conductscience.org/library/papers/41148672PubMed
33,027,987
The Antibacterial and Anti-biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of Pseudomonas Aeruginosa from Irish Cystic Fibrosis Patients.
Antibiotics (Basel)2020https://conductscience.org/library/papers/33027987PubMed
31,057,792A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections.Antimicrob Resist Infect Control2019https://conductscience.org/library/papers/31057792PubMed
30,904,374Antipseudomonal monotherapy or combination therapy for older adults with community-onset pneumonia and multidrug-resistant risk factors: a retrospective cohort study.Am J Infect Control2019https://conductscience.org/library/papers/30904374PubMed
29,456,647Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies.Exp Ther Med2018https://conductscience.org/library/papers/29456647PubMed
26,031,965Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.Curr Infect Dis Rep2015https://conductscience.org/library/papers/26031965PubMed
24,955,088In vitro antibacterial effect of wasp (Vespa orientalis) venom.J Venom Anim Toxins Incl Trop Dis2014https://conductscience.org/library/papers/24955088PubMed
24,655,422Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.BMC Infect Dis2014https://conductscience.org/library/papers/24655422PubMed
24,184,742An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Virulence2014https://conductscience.org/library/papers/24184742PubMed
23,593,006The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations.PLoS Pathog2013https://conductscience.org/library/papers/23593006PubMed
23,157,735Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia.BMC Infect Dis2012https://conductscience.org/library/papers/23157735PubMed
22,763,634Combination therapy for treatment of infections with gram-negative bacteria.Clin Microbiol Rev2012https://conductscience.org/library/papers/22763634PubMed
19,164,144Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19164144PubMed
8,843,303Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8843303PubMed
8,457,980Gram-negative sepsis: a dilemma of modern medicine.Clin Microbiol Rev1993https://conductscience.org/library/papers/8457980PubMed
7,399,713Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis.Infection1980https://conductscience.org/library/papers/7399713PubMed
7,379,929Antimicrobial chemotherapy - a clinician's viewpoint.Experientia1980https://conductscience.org/library/papers/7379929PubMed
6,792,982Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6792982PubMed
6,775,591Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6775591PubMed
6,538,773In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6538773PubMed

See all 45 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/412648

GET https://conductscience.org/api/papers/v1/412648/cited_by?page=2